Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jodie C, Hamrick"'
Autor:
Cassandra L, Chatwin, Jodie C, Hamrick, Robert E L, Trout, Cullen L, Myers, Susan M, Cusick, William J, Weiss, Mark E, Pulse, Luigi, Xerri, Christopher J, Burns, Gregory, Moeck, Denis M, Daigle, Kaitlyn, John, Tsuyoshi, Uehara, Daniel C, Pevear
Publikováno v:
Antimicrobial Agents and Chemotherapy
There is an urgent need for oral agents to combat resistant Gram-negative pathogens. Here, we describe the characterization of VNRX-5236, a broad-spectrum boronic acid β-lactamase inhibitor (BLI), and its orally bioavailable etzadroxil prodrug, VNRX
Autor:
Jodie C, Hamrick, Jean-Denis, Docquier, Tsuyoshi, Uehara, Cullen L, Myers, David A, Six, Cassandra L, Chatwin, Kaitlyn J, John, Salvador F, Vernacchio, Susan M, Cusick, Robert E L, Trout, Cecilia, Pozzi, Filomena, De Luca, Manuela, Benvenuti, Stefano, Mangani, Bin, Liu, Randy W, Jackson, Greg, Moeck, Luigi, Xerri, Christopher J, Burns, Daniel C, Pevear, Denis M, Daigle
Publikováno v:
Antimicrobial Agents and Chemotherapy
As shifts in the epidemiology of β-lactamase-mediated resistance continue, carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) are the most urgent threats.
As shifts in the epidemiology of β-lacta
As shifts in the epidemiology of β-lacta